Concepedia

Mohammed Alnaggar

MA

Statistics

Publications

10

Citations

751

H-Index

10

Active since

2014

Affiliations

Jinan University(Current)

Fuda Cancer Hospital

Huazhong University of Science and Technology

Tongji Hospital

First Affiliated Hospital of Jinan University

Mohammed Alnaggar is an author at Jinan University specializing in radiation oncology, medicine, and oncology.

ORCID

Top concepts

Publications per year

2014–2023

10

Publications

10

Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer

Yan Xu, Zheng Xiang, Mohammed Alnaggar et al. · Cellular and Molecular Immunology · 2020 · 232 citations · Full text

Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma

Mohammed Alnaggar, Yan Xu, Jingxia Li et al. · Journal for ImmunoTherapy of Cancer · 2019 · 125 citations · Full text

Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: an open-label, single-arm, phase II trial (RENMIN-215)

Wensi Zhao, Jun Lei, Shaobo Ke et al. · EClinicalMedicine · 2023 · 95 citations · Full text

, , +8

Irreversible electroporation plus allogenic Vγ9Vδ2 T cells enhances antitumor effect for locally advanced pancreatic cancer patients

Mao Lin, Xiaoyan Zhang, Shuzhen Liang et al. · Signal Transduction and Targeted Therapy · 2020 · 88 citations · Full text

Allogenic Natural Killer Cell Immunotherapy Combined with Irreversible Electroporation for Stage IV Hepatocellular Carcinoma: Survival Outcome

Mohammed Alnaggar, Mao Lin, Adnan Mesmar et al. · Cellular Physiology and Biochemistry · 2018 · 66 citations · Full text

1–5 of 10